Global Competition Review has ranked Goodwin as a Highly Recommended firm in Massachusetts in the 2022 edition of the GCR 100. For over two decades, GCR 100 has conducted in-depth research to provide a quantitative and qualitative analysis of the law firms and economic consultancies doing the most important antitrust work in nearly 60 jurisdictions around the world.
Goodwin’s Antitrust & Competition practice has unparalleled expertise in handling the full range of antitrust matters from merger clearance to complex litigation. Known for decades of experience and the ability to solve complex problems, Goodwin lawyers have advised clients ranging from the largest Fortune 500 companies to emerging growth companies on more than 2,500 transactions before U.S. and international antitrust agencies. The team has also successfully defended hundreds of matters through the Second Request process and other intensive government investigations.
GCR 100 highlighted Goodwin’s work representing Actavis throughout litigation challenging the global pharmaceutical company’s patent settlement agreement with Shire. It also noted the firm’s representation of Teva, Barr Pharmaceuticals and Cobalt Laboratories in litigation related to the release of the generic version of a pharmaceutical designed to treat dementia.
To see the full GCR 100 2022 and learn more about Goodwin’s practice, click here.